Gelteq Limited (GELS)

Gelteq will go public soon, but the exact IPO date is still unknown.
IPO Price
$5.00
Shares Offered
1,300,000
Deal Size
$6,500,000
Chart not available yet
Data will show when the stock starts trading.
Market Cap 47.80M
Revenue (ttm) 353
Net Income (ttm) -1.68M
Shares Out 9.56M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About GELS

Gelteq is a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. A “white label” gel-based delivery solution is where we produce a product that other companies rebrand as their own product. Our principal products are edible gels and their application in gel-based dosage forms. Our current product suite consists of multiple products that sit within five core verticals — for pets, sports, pharmaceutic... [Read more...]

Industry Health Care
Founded 2018
CEO Nathan J. Givoni
Employees 5
Stock Exchange NASDAQ
Ticker Symbol GELS
Full Company Profile

Financial Performance

Financial numbers in AUD Financial Statements

News

Gelteq IPO Registration Document (F-1)

Gelteq has filed to go public with an IPO on the NASDAQ.

1 month ago - SEC